ArticleCancer gene therapy2023

Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine.

D C A Quixabeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.